CN109790206A - 重组结合蛋白及其用途 - Google Patents

重组结合蛋白及其用途 Download PDF

Info

Publication number
CN109790206A
CN109790206A CN201780058511.0A CN201780058511A CN109790206A CN 109790206 A CN109790206 A CN 109790206A CN 201780058511 A CN201780058511 A CN 201780058511A CN 109790206 A CN109790206 A CN 109790206A
Authority
CN
China
Prior art keywords
ala
leu
gly
asp
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201780058511.0A
Other languages
English (en)
Chinese (zh)
Inventor
C·梅茨
U·菲德勒
I·多拉多
H·M·施特罗贝尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Molecular Partners AG
Original Assignee
Molecular Partners AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Molecular Partners AG filed Critical Molecular Partners AG
Publication of CN109790206A publication Critical patent/CN109790206A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN201780058511.0A 2016-09-22 2017-09-20 重组结合蛋白及其用途 Pending CN109790206A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16190221.8 2016-09-22
EP16190221 2016-09-22
PCT/EP2017/073768 WO2018054971A1 (en) 2016-09-22 2017-09-20 Recombinant binding proteins and their use

Publications (1)

Publication Number Publication Date
CN109790206A true CN109790206A (zh) 2019-05-21

Family

ID=57046984

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201780058511.0A Pending CN109790206A (zh) 2016-09-22 2017-09-20 重组结合蛋白及其用途

Country Status (20)

Country Link
US (2) US10717772B2 (cg-RX-API-DMAC7.html)
EP (1) EP3515933B9 (cg-RX-API-DMAC7.html)
JP (1) JP6976335B2 (cg-RX-API-DMAC7.html)
KR (1) KR102270315B1 (cg-RX-API-DMAC7.html)
CN (1) CN109790206A (cg-RX-API-DMAC7.html)
AR (1) AR109680A1 (cg-RX-API-DMAC7.html)
AU (1) AU2017331329B2 (cg-RX-API-DMAC7.html)
BR (1) BR112019005587A2 (cg-RX-API-DMAC7.html)
CA (1) CA3036301C (cg-RX-API-DMAC7.html)
CL (1) CL2019000729A1 (cg-RX-API-DMAC7.html)
CO (1) CO2019002609A2 (cg-RX-API-DMAC7.html)
ES (1) ES2953516T3 (cg-RX-API-DMAC7.html)
IL (1) IL265489B (cg-RX-API-DMAC7.html)
MX (1) MX377424B (cg-RX-API-DMAC7.html)
MY (1) MY196882A (cg-RX-API-DMAC7.html)
NZ (1) NZ751689A (cg-RX-API-DMAC7.html)
PH (1) PH12019500596B1 (cg-RX-API-DMAC7.html)
SA (1) SA519401369B1 (cg-RX-API-DMAC7.html)
WO (1) WO2018054971A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201901592B (cg-RX-API-DMAC7.html)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114206943A (zh) * 2019-06-04 2022-03-18 分子伴侣公司 多特异性蛋白质
CN114222757A (zh) * 2019-06-04 2022-03-22 分子伴侣公司 重组4-1bb结合蛋白及其用途
CN114269366A (zh) * 2019-06-04 2022-04-01 分子伴侣公司 重组fap结合蛋白及其用途
CN115916815A (zh) * 2020-05-06 2023-04-04 分子合作伙伴股份公司 新型锚蛋白重复结合蛋白及其用途

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220016944A (ko) 2019-06-04 2022-02-10 몰리큘라 파트너스 아게 개선된 안정성을 갖는 설계된 안키린 반복 도메인
AU2020402581A1 (en) 2019-12-11 2022-06-23 Molecular Partners Ag Designed ankyrin repeat domains with altered surface residues
IL298168A (en) 2020-05-14 2023-01-01 Molecular Partners Ag Multispecific proteins
AU2021271131A1 (en) * 2020-05-14 2022-12-15 Molecular Partners Ag Recombinant CD40 binding proteins and their use
US20240108746A1 (en) 2020-12-16 2024-04-04 Molecular Partners Ag Novel slow-release prodrugs
US20240317852A1 (en) 2021-03-09 2024-09-26 Molecular Partners Ag Novel darpin based cd33 engagers
WO2022190016A1 (en) 2021-03-09 2022-09-15 Molecular Partners Ag Novel darpin based multi-specific t-cell engagers
CA3211368A1 (en) 2021-03-09 2022-09-15 Molecular Partners Ag Novel darpin based cd123 engagers
EP4305063A1 (en) 2021-03-09 2024-01-17 Molecular Partners AG Protease cleavable prodrugs
WO2023110983A1 (en) 2021-12-14 2023-06-22 Molecular Partners Ag Designed repeat domains with dual binding specificity and their use
CA3262553A1 (en) 2022-08-01 2024-02-08 Molecular Partners Ag REHEARSAL AREAS DESIGNED WITH MODIFIED CHARGES AND THEIR USE
WO2024038307A1 (en) 2022-08-19 2024-02-22 Novartis Ag Dosing regimens for sars-cov-2 binding molecules
IL322519A (en) 2023-02-17 2025-10-01 Ablynx Nv Polypeptides that bind to the neonatal fc receptor
EP4673159A1 (en) 2023-02-27 2026-01-07 Molecular Partners AG Darpins for use in reducing renal accumulation of drugs
JP2026524079A (ja) 2023-06-06 2026-07-17 モレキュラー パートナーズ アクチェンゲゼルシャフト 組換えcd2結合タンパク質及びその使用
WO2024251628A1 (en) 2023-06-06 2024-12-12 Molecular Partners Ag Recombinant cd16a binding proteins and their use
WO2025146491A1 (en) 2024-01-05 2025-07-10 Molecular Partners Ag Designed repeat domains with dual binding specificity for cd117 and cd47-binding agent
CN122438868A (zh) 2024-01-05 2026-07-21 分子合作伙伴股份公司 多特异性结合蛋白
WO2025163144A1 (en) 2024-01-31 2025-08-07 Molecular Partners Ag Recombinant mesothelin binding proteins and their use
WO2025163082A1 (en) * 2024-01-31 2025-08-07 Molecular Partners Ag Dll3-specific binding constructs and their use in radiotherapy
WO2025181039A1 (en) 2024-03-01 2025-09-04 Molecular Partners Ag Therapeutic combinations comprising a multi-specific t cell engager
WO2026013280A1 (en) * 2024-07-11 2026-01-15 Johann Wolfgang Goethe-Universität Frankfurt am Main Designed ankyrin repeat proteins binding p53, and uses thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1636017A (zh) * 2001-08-24 2005-07-06 维多利亚大学创新和发展公司 含有蛋白酶激活序列的气单胞菌溶素原及其在前列腺癌治疗中的使用方法
CN103459415A (zh) * 2010-11-26 2013-12-18 分子组合公司 设计的与血清白蛋白结合的重复蛋白
WO2014060365A1 (en) * 2012-10-15 2014-04-24 Universität Zürich Prorektorat Mnw Bispecific her2 ligands for cancer therapy
WO2014083208A1 (en) * 2012-11-30 2014-06-05 Molecular Partners Ag Binding proteins comprising at least two repeat domains against her2

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE509359C2 (sv) 1989-08-01 1999-01-18 Cemu Bioteknik Ab Användning av stabiliserade protein- eller peptidkonjugat för framställning av ett läkemedel
US7371376B1 (en) 1996-10-18 2008-05-13 Genentech, Inc. Anti-ErbB2 antibodies
EP1332209B1 (en) 2000-09-08 2009-11-11 Universität Zürich Collections of repeat proteins comprising repeat modules
KR20070085314A (ko) 2004-11-12 2007-08-27 바이엘 쉐링 파마 악티엔게젤샤프트 재조합 뉴캐슬 질환 바이러스
KR101268939B1 (ko) 2005-07-08 2013-05-30 유니버시티 오브 취리히 융합 폴리펩티드의 공번역 전좌를 사용한 파아지디스플레이
CA2700391A1 (en) 2007-09-24 2009-04-02 University Of Zuerich Designed armadillo repeat proteins
CA2706425A1 (en) 2007-11-27 2009-06-04 Ablynx N.V. Method for obtaining polypeptide constructs comprising two or more single domain antibodies
NZ592591A (en) 2008-11-03 2012-04-27 Molecular Partners Ag Binding proteins comprising ankyrin repeast domains that inhibit the vegf-a receptor interaction
TWI510246B (zh) 2010-04-30 2015-12-01 Molecular Partners Ag 抑制vegf-a受體交互作用的經修飾結合性蛋白質
WO2012149439A2 (en) 2011-04-29 2012-11-01 Janssen Biotech, Inc. Il4/il13 binding repeat proteins and uses
SG11201408196RA (en) 2012-06-28 2015-03-30 Molecular Partners Ag Designed ankyrin repeat proteins binding to platelet-derived growth factor
US11453708B2 (en) 2013-05-31 2022-09-27 Molecular Partners Ag Designed ankyrin repeat proteins binding to hepatocyte growth factor
US9458211B1 (en) * 2015-04-02 2016-10-04 Molecular Partners Ag Recombinant proteins that simultaneously bind HGF, VEGF-A and serum albumin, comprising ankyrin repeat domains

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1636017A (zh) * 2001-08-24 2005-07-06 维多利亚大学创新和发展公司 含有蛋白酶激活序列的气单胞菌溶素原及其在前列腺癌治疗中的使用方法
CN103459415A (zh) * 2010-11-26 2013-12-18 分子组合公司 设计的与血清白蛋白结合的重复蛋白
KR20140032356A (ko) * 2010-11-26 2014-03-14 몰리큘라 파트너스 아게 설계된 안키린 반복 단백질에 대한 개선된 n-말단 캡핑 모듈
WO2014060365A1 (en) * 2012-10-15 2014-04-24 Universität Zürich Prorektorat Mnw Bispecific her2 ligands for cancer therapy
WO2014083208A1 (en) * 2012-11-30 2014-06-05 Molecular Partners Ag Binding proteins comprising at least two repeat domains against her2
CN104918959A (zh) * 2012-11-30 2015-09-16 分子组合公司 包含至少两个针对her2的重复序列结构域的结合蛋白

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114206943A (zh) * 2019-06-04 2022-03-18 分子伴侣公司 多特异性蛋白质
CN114222757A (zh) * 2019-06-04 2022-03-22 分子伴侣公司 重组4-1bb结合蛋白及其用途
CN114269366A (zh) * 2019-06-04 2022-04-01 分子伴侣公司 重组fap结合蛋白及其用途
CN115916815A (zh) * 2020-05-06 2023-04-04 分子合作伙伴股份公司 新型锚蛋白重复结合蛋白及其用途

Also Published As

Publication number Publication date
CA3036301C (en) 2021-04-20
SA519401369B1 (ar) 2022-12-22
AU2017331329A1 (en) 2019-04-04
KR20190050802A (ko) 2019-05-13
US20180155402A1 (en) 2018-06-07
CA3036301A1 (en) 2018-03-29
IL265489B (en) 2021-07-29
WO2018054971A1 (en) 2018-03-29
JP2019531093A (ja) 2019-10-31
EP3515933B9 (en) 2023-08-16
EP3515933A1 (en) 2019-07-31
US20210130420A1 (en) 2021-05-06
MX2019003298A (es) 2019-09-26
CO2019002609A2 (es) 2019-05-31
EP3515933B1 (en) 2023-06-07
CL2019000729A1 (es) 2019-06-14
MY196882A (en) 2023-05-08
KR102270315B1 (ko) 2021-06-29
RU2019111628A (ru) 2020-10-19
RU2019111628A3 (cg-RX-API-DMAC7.html) 2020-10-30
PH12019500596B1 (en) 2024-02-21
ES2953516T3 (es) 2023-11-14
NZ751689A (en) 2021-07-30
JP6976335B2 (ja) 2021-12-08
ZA201901592B (en) 2021-04-28
BR112019005587A2 (pt) 2019-06-11
AR109680A1 (es) 2019-01-09
IL265489A (en) 2019-05-30
PH12019500596A1 (en) 2019-07-29
US10717772B2 (en) 2020-07-21
EP3515933C0 (en) 2023-06-07
AU2017331329B2 (en) 2020-10-29
MX377424B (es) 2025-03-10

Similar Documents

Publication Publication Date Title
KR102270315B1 (ko) 재조합 결합 단백질 및 그의 용도
KR102290592B1 (ko) Her2에 대항하는 적어도 두 개 이상의 반복 도메인을 포함하는 결합 단백질
JP6041799B2 (ja) Trailr2特異的多量体足場
KR20190008938A (ko) 단일 쇄 가변 단편 cd3 결합 단백질
CN113278077A (zh) 设计的与血清白蛋白结合的重复蛋白
JP2023554379A (ja) 組換えcd3結合タンパク質及びそれらの使用
RU2778346C2 (ru) Рекомбинантные связывающие белки и их применение
CN117242100A (zh) 基于DARPin的新型CD70接合物
CN116802213A (zh) 重组cd3结合蛋白及其用途
HK40006908A (en) Recombinant binding proteins and their use
HK40006908B (en) Recombinant binding proteins and their use
BR112015012436B1 (pt) Proteína de ligação recombinante e formulação farmacêutica

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
AD01 Patent right deemed abandoned
AD01 Patent right deemed abandoned

Effective date of abandoning: 20250214